[Mai zuwa wani babi ne na littafin Lori Weintz, Hanyoyin cutarwa: Magunguna a Lokacin Covid-19.]
Akwai ta da yawa a intanet game da…hydroxychloroquine [maganin da] an amince da shi shekaru da yawa, mai arha, ana amfani da shi wajen zazzabin cizon sauro da wasu cututtuka na autoimmune.
Anthony Fauci, Daraktan NIAID
Kwamitin Task Force na Fadar White House
Maris 19, 2020
Fauci, a cikin watan Afrilu na 2020 ba zai iya yin watsi da HCQ kawai ba, duk da fifikon sa don samun riba mai riba - ba tare da duk wannan "kuɗi akan intanet ba." "Babban abin mamaki" yana da alaƙa da likitocin da ke samun nasarar yin maganin marasa lafiya na Covid tare da hydroxychloroquine. Bugu da ƙari a kan Maris 28, 2020 FDA ta ba da izinin amfani da gaggawa na HCQ don kula da Covid. Yana da mahimmanci a bayyana cewa an ba HCQ dama mai mahimmanci, amma binciken da NIH ta haɗa shi ne ƙoƙari na rabin zuciya a mafi kyau, kuma an tsara shi don kasawa a mafi muni.
NIH "binciken" ya ce HCQ baya tasiri a cikin Covid-19, yana ƙaruwa da mace-mace:
In Afrilu 2020 NIH ta yi ɗan gajeren nazari na baya A kan HCQ, ma'ana sun bincika bayanan wasu ɗari biyu maza sama da shekaru 65 a asibitocin VA, kuma sun sami "babu wata shaida da ke nuna cewa amfani da hydroxychloroquine, ko dai tare da ko ba tare da azithromycin ba, ya rage haɗarin samun iskar inji a cikin marasa lafiya da ke asibiti tare da Covid-19." Binciken ya kuma ƙaddamar da cewa gabaɗayan mace-mace ya karu a cikin marasa lafiya da aka yi wa HCQ.
Abin da binciken Hukumar Tsohon Sojan Sama na NIH ya kasa nuna shi ne cewa HCQ ya fi tasiri a farkon bayyanar cututtuka yayin matakin kwafi, ba lokacin da majinyacin Covid ba ya da lafiya don a kwantar da shi a asibiti da kuma lokacin kumburin cutar.
An Associated Press labarin da aka buga lokacin da aka fitar da rahoton VA a ranar 21 ga Afrilu, 2020 ya ce, "Magungunan (HCQ) ya daɗe da sanin yana da illa mai haɗari, gami da canza bugun zuciya ta hanyar da za ta iya haifar da mutuwa kwatsam."
Wani yana ciyar da kafofin watsa labarai ɓata bayanai game da HCQ. Sanannen abu ne cewa HCQ zai yi tasiri ga zuciya ne kawai ta hanyar da ba ta dace ba idan aka ba shi da yawan allurai, dangane da tsawon shekarun da suka gabata na bayanan aminci. Hakanan, akwai misalai da yawa na gaske na duniya waɗanda suka saba wa “binciken” NIH.
Na shiga shakku lokacin da hukumomin kiwon lafiya suka fara wani fafutuka na yaƙi da hydroxychloroquine, wanda na san magani ne mai aminci saboda ni daga masana'antar ne, kuma na saba da shi. Na duba musamman game da batun cewa suna sanya shi a cikin ƙarya, wanda shine tsawaitawar QT (cututtukan alamar zuciya) da arrhythmias da ke hade da tsawaita QT na miyagun ƙwayoyi. Ya kasance yankin da aka fi mayar da hankali ga kamfani na ƙarshe wanda nake da shi kuma na yi aiki tare da shi a cikin kantin magani. Na san abin da suke faɗa game da wannan maganin ba gaskiya ba ne.
Kara mahimmanci, masu mulki sun san sarai cewa suna faɗin abubuwan da ba gaskiya ba ne. Hakan ya ba ni dakata. Na fara tunani, "Su kwararru ne, sun san wannan batu, sun san wannan bayanan, duk da haka suna faɗin abubuwan da ba gaskiya ba ne." Hakan ya sa na fara tambayar komai. Idan ka kama wani jami'i ko kwararre yana karyar wani abu kai tsaye ga jama'a, me kuma suke yi? (An ƙara jaddadawa)
Sasha Latypova
Tsohon Babban Jami'in Magunguna
Yuni 17, 2023
Dr. Vladimir Zelenko yana amfani da HCQ don samun nasarar kula da marasa lafiya na Covid 2,000:
A farkon barkewar cutar, likitan dangi Dr. Vladimir “Zev” Zelenko ya haɓaka a yarjejeniya mai nasara don maganin Covid-19. A cikin farkon watanni, Dr. Zelenko ya kula da marasa lafiya na Covid sama da 2,000. Ga masu buƙatar magani, ya yi amfani da haɗin HCQ, zinc, da azithromycin (AZ) ko doxycycline, dangane da mai haƙuri.
Manufarsa ita ce kula da marasa lafiya da ke cikin haɗari yayin Stage 1 na Covid, matakin kamuwa da cuta, wanda ya hana shi haɓaka zuwa cuta mai tsanani. Daga cikin marasa lafiya 2,000, yawancinsu tsofaffi, duk sun murmure ba tare da wani sakamako na dogon lokaci ba, sai dai marasa lafiya biyu da suka sami wasu matsalolin lafiya kuma suka mutu. Maganin Dr. Zelenko ya hana kashi 84% na marasa lafiya na Covid fita daga asibiti. Ya lura da lalacewar huhu na dogon lokaci a cikin waɗanda aka kwantar da su a asibiti kuma aka sanya injin iska.
Dr. Didier Raoult ya yi nasarar kula da marasa lafiya sama da 1,000 tare da haɗakar HCQ/AZ:
A Marseilles, Faransa, tawagar Dr. Didier Raoult sun gudanar da wani nazarin marasa lafiya 1,061 An yi maganin Covid tare da haɗin HCQ da azithromycin daga 3 ga Maris zuwa Afrilu 9, 2020. Binciken ya ruwaito, "An sami kyakkyawan sakamako na asibiti da kuma maganin virological a cikin marasa lafiya 973 a cikin kwanaki 10 (91.7%)."
Haɗin HCQ-AZ, lokacin da aka fara kai tsaye bayan ganewar asali, magani ne mai aminci da inganci ga COVID-19, tare da adadin mace-mace na 0.5%, a cikin tsofaffi marasa lafiya. Yana guje wa muni kuma yana share dagewar ƙwayoyin cuta da kamuwa da cuta a mafi yawan lokuta.
Fassarar nazarin Marseilles, Faransa
An buɗe Maris 3 - Afrilu 9, 2020
Masanin kimiyyar ƙwayoyin cuta da na asibiti, Raoult shine ƙwararren ƙwararrun cututtukan cututtukan da aka buga sosai a Turai, kuma shine wanda ya kafa kuma shugaban asibitin bincike na IHN Mediterranee, babban cibiyar cututtukan cututtuka a Faransa. Raoult ya saba da binciken farko na HCQ a matsayin mai hana cutar ci gaban cutar coronavirus. Wataƙila rahoton nasa ya yi tasiri a cikin amincewar farko na FDA na HCQ don kula da Covid.
HCQ ba zato ba tsammani a matsayin "abu mai guba" a Faransa:
HCQ ta kasance kan-da-counter a Faransa shekaru da yawa kafin wasu abubuwan da suka faru a bayan fage siyasa Maneuvering ya kai ga reclassification a matsayin "abu mai guba" a cikin Janairu 2020.
Lokacin da Raoult ya fitar da bincikensa a watan Mayu 2020, umarnin don HCQ ya tashi daga matsakaita na 50 a kowace rana zuwa ɗari da yawa, sannan har ma dubbai. Gwamnatin Faransa da sauri ya dauki mataki don ba da shawarar kada a rubuta shi ga Covid sai dai a cikin gwaje-gwajen asibiti, a wani bangare dangane da binciken Surgisphere da aka gurbata. (Dubi cin hanci da rashawa na mujallun likitanci:)
Raoult ya ci gaba da samun nasara ta amfani da HCQ, hade da wasu magunguna, a matsayin magani ga Covid-19. Daga Maris 2020 zuwa Disamba 2021 Raoult ya gudanar da wata ƙungiya ta baya-bayan nan binciken na marasa lafiya 30,423 Covid-19. Wani samfurin da aka riga aka buga na binciken ya kammala da cewa, "HCQ da aka tsara da wuri ko kuma a makare yana ba da kariya daga wani bangare daga mutuwar COVID-19."
Zai bayyana cewa Raoult ne ya toka kuryar zoho a cikin gudanar da bincike na yau da kullun ta amfani da magunguna na yau da kullun tare da bayanan martaba na tsawon shekaru da yawa. Bayan an buga pre-bugu na binciken a cikin Maris 2023, rukuni na Hukumomin bincike na Faransa ya yi kira da a ladabtar da Raoult don "rubutun magunguna daban-daban kamar hydroxychloroquine, zinc, ivermectin da azithromycin ga marasa lafiya da ke fama da Covid-19 ba tare da ingantaccen tushen harhada magunguna ba kuma ba su da wata hujja ta tasirin su."
Kawai don bita: Hydroxychloroquine da ivermectin suna cikin jerin mahimman magunguna na Hukumar Lafiya ta Duniya kuma kusan ba su da illa ko mu'amala da wasu magunguna. Zinc shine sinadari mai mahimmanci da ake samu a cikin nau'ikan kayan shuka da abinci na dabba kuma ana samun su ta sigar kwaya a kowane kantin magani. Azithromycin wani maganin rigakafi ne wanda aka yi wa wajabta ta ko'ina shekaru da yawa kuma shine mahimmin magani na WHO. Likitoci da yawa da daruruwan karatu sun sami cikakkiyar shaida cewa waɗannan da sauran magungunan kashe-kashen suna da tasiri wajen kula da marasa lafiyar Covid. Menene waɗannan ƙungiyoyin bincike na Faransa suka damu da haka?
Ana tsananta wa likitocin da suka yi tambaya game da labarin hukuma:
Kafin a ci gaba, ya zama dole a nuna hakan kowane likita da aka ambata a cikin wannan takarda, wanda ya yi tambaya game da labarin Covid-19 na hukuma, ya fuskanci zalunci na jama'a da ƙwararru. Shigar da kowane sunansu a cikin injin bincike kuma jerin za su bayyana na munanan labaran da ke lalata halayensu da takaddun shaida. An rasa ayyukan yi, an hukunta su, an yi musu hasarar kuɗi, kuma an yi musu barazana da ayyuka a kan lasisin aikin likita da takaddun shaida.
Yana da mahimmanci mu tambayi kanmu dalilin da yasa waɗannan ƙwararrun, waɗanda kafin cutar ta Covid-19 ana mutunta su sosai kuma suna da ayyuka masu nasara, za su ba da kansu ga irin abin ba'a da cutarwa - na ƙwararru da na kuɗi, waɗanda suka dandana don tambayar labarin cutar ta hukuma. Zai fi sauƙi a tafi tare da shiru.
Wannan juyowa ga 'yancin faɗar albarkacin baki da tunani a cikin magani, da sauran fagage na rayuwarmu, ya kamata ya damu da mu duka.
Dr. Meryl Nass yayi bitar amfani da HCQ mai guba a cikin gwajin farfadowa da haɗin kai:
A watan Yuni 2020 Dr. Meryl Nass likita ne mai aiki a Maine. A cikin shekarun da suka gabata Dr. Nass ya ba da shaida a gaban Majalisa sau da yawa game da tsoron Anthrax da ta'addanci, a tsakanin sauran batutuwa. Bayan da Ma'aikatar Lafiya ta Indiya ta tuntube ta tare da wasu damuwa, Dr. Nass ya jagoranci yin nazari biyu manyan karatun HCQ - Gwajin farfadowa da Gwajin Haɗin kai.
The Gwajin farfadowa, kokarin hadin gwiwa da gwamnatin Burtaniya, da Wellcome Trust, da gidauniyar Bill & Melinda Gates, ya kare ne a farkon watan Yuni, inda aka kammala cewa HCQ ba ta rage cutar ta Covid ba, kuma ta haifar da karuwar mutuwar marasa lafiya.
Kasashe da dama na WHO Gwajin hadin kai kwanan nan sun dawo hannun HCQ na binciken wanda suka dakata a watan Mayu 2020 saboda rahotanni daga binciken Surgisphere da aka buga a cikin Lancet, mujallar likita ta farko. The Nazarin Surgisphere, wanda ya yi iƙirarin cewa majinyatan da suka karɓi chloroquine ko HCQ suna da adadin masu mutuwa sama da kashi 35%, an ɗauke su kwanaki 13 bayan buga, saboda an ƙaddara ƙirƙira bayanan sa.
Cin hanci da rashawa na jaridun likita:
Mujallun likitanci masu tasiri sun taka rawar gani sosai a cikin adadin mutane na Covid ta hanyar yin la'akari da ingantaccen binciken magungunan da aka sake dawo dasu kamar hydroxychloroquine da ivermectin. Sun buga jarrabawa na yaudara a fili waɗanda aka tsara don gazawa; don nuna cewa ivermectin bai yi aiki ba, kuma don nuna cewa hydroxychloroquine bai yi aiki ba. Sun kuma yi amfani da gwaje-gwajen da ke nuna aminci da ingancin maganin.
Dokta Pierre Kory
Kwararren Kulawa na Huhu & Mahimmanci
Co-kafa FLCCC
The Surgisphere yanki ne a abin kunya a masana'antar jarida ta likitanci game da yadda irin wannan shoddy da gurbataccen karatu sanya shi ta hanyar nazari na takwarorinsu da kuma buga. Maimakon zama abin rashin ƙarfi, binciken Surgisphere ya zama Alamar cin hanci da rashawa a cikin tantancewa da kuma bitar takwarorinsu na labarai a cikin manyan mujallun likitanci a lokacin Covid.
Daya daga cikin matsalolin da janye karatu irin su Surgisphere su ne a ci gaba da ambato su kamar halal ne. Taros da abokan aiki samu a wani bincike cewa "An ba da misalin labaran da aka janye a matsakaicin sau 44.8" wanda ya fi matsakaici. Sun kuma gano cewa kasancewar kalmomin “janye” ko “dakewa” kafin taken labarin bai shafi adadin ƙididdiga ba.
A cikin yanayin binciken karya, ja da baya ya zama dole. Amma mujallu da yawa sun daina ba da cikakken bayani game da dalilin da ya sa ake janye labaran. Misali, Jessica Rose da Dokta Peter McCullough sun gabatar da wani bincike kan cutar myocarditis mai alaka da alurar riga kafi ga mujallar. Matsalolin Yanzu A Cikin Ilimin Zuciya. An yarda da binciken da aka yi bita don bugawa, amma ba tare da bayani ba, ya kasance janye. McCullough ya tabbata an janye binciken saboda shi bai goyi baya ba labari na hukuma cewa rigakafin Covid yana da lafiya kuma yana da tasiri. Rose da McCullough sun gano cewa 3,569/3,594 (99.3%) lokuta na myocarditis da ke buƙatar asibiti ba su da alaƙa da cutar numfashi ta Covid-19, amma suna da alaƙa na ɗan lokaci da rigakafin Covid-19. A ƙarshe an jera binciken akan Zenodo, ma'ajiyar buɗaɗɗen manufa ta gaba ɗaya.
Bayan binciken Surgisphere an ƙaddara cewa za a gurbata shi, an ci gaba da gwajin Solidarity. Dr. Nass ya lura cewa a cikin Solidarity, farfadowa, da REMAP (wani gwaji yana duba yiwuwar maganin Covid), Ana ba da hydroxychloroquine ne kawai ga marasa lafiya a asibiti. HCQ ya fi tasiri a farkon, kwafin kwayar cuta, mataki na cutar Covid-19, kuma shine ba ya da tasiri sosai ga wanda ya riga ya yi rashin lafiya isa asibiti.
An ba da allurai masu guba na HCQ ga mahalarta gwaji:
Amma ban da gaskiyar cewa suna ba da HCQ a daidai lokacin kamuwa da cutar Covid, Dr. Nass ya firgita da sanin hakan. duka Gwajin Haɗin kai da Farfaɗowa sun kasance suna ba da allurai masu guba na HCQ ga mahalarta gwaji. Ma'aikatar lafiya ta Indiya, wacce ta sami babban nasara ta amfani da HCQ don kula da Covid-19, ta sanar da Nass cewa sun tuntubi WHO tare da damuwar da Trial Solidarity ke amfani da shi. sau hudu daidaitattun kashi. Ko mafi muni, a cikin binciken REMAP, marasa lafiyar da aka yi niyya don gudanar da HCQ sun riga sun kasance a kan na'urar hura iska ko a gigice. Wato, marasa lafiya da suka riga sun kusa mutuwa sun kasance an ba da allurai masu guba Farashin HCQ.
Nass ya ce, "[HCQ] yana da aminci sosai idan aka yi amfani da shi daidai, amma ba da yawa ba na iya kashewa." Mashawarcin da WHO ta dauka a ciki 1979, H. Weniger, ya kalli sassan 335 na guba na manya ta hanyar magungunan chloroquine, lura da cewa kashi ɗaya na 1.5 zuwa 2 grams na tushen chloroquine "na iya zama mai mutuwa." Gwajin farfadowa ya yi amfani da gram 2.4 a cikin sa'o'i 24 na farko na jiyya, da kuma adadin gram 9.2 a cikin kwanaki 10. Gwajin Solidarity yayi amfani da gram 1.55 na tushen HCQ a cikin sa'o'i 24 na farko. Nass ya kammala da cewa, "Kowace gwaji ta ba marasa lafiya adadi mai yawa a cikin sa'o'i 24 na farko wanda, lokacin da aka ba da shi azaman kashi ɗaya, an rubuta cewa yana iya mutuwa.
Nass ya tabbatar da cewa yawan adadin HCQ a cikin gwaje-gwajen ba a ba da shawarar ba wani yanayin jiyya bisa ga lakabin Amurka na miyagun ƙwayoyi, da maɓuɓɓugan ma'anar magunguna daban-daban.
[gwajin] ba, a zahiri, gwada fa'idodin HCQ akan Covid-19, amma a maimakon haka [suna] gwada ko marasa lafiya sun tsira da guba, allurai marasa magani.
Meryl Nass
A ranar 15 ga watan Yuni, Dr. Nass ya tuntubi Darakta Janar na WHO Tedros Ghebreyesus inda ta sanar da shi sakamakon binciken da ta yi. da kuma nuna cewa darektocin gwaji, da WHO, za su kasance masu alhakin lalacewa idan ba a sanar da batutuwan gwaji ba game da sanannun haɗarin da ke da alaƙa da yawan allurai na HCQ. A ranar 17 ga watan Yuni ne WHO ta kawo karshen gwajin Solidarity kwatsam, da'awar yanke shawarar ya dogara ne akan sakamakon gwajin farfadowa, a tsakanin sauran bayanai.
Dokta Nass ta ci gaba da yin kira ga keta ka'idojin likitancin da ta lura yayin bala'in. Musamman ma, ta yi la'akari da al'ada mai haɗari na tsoma bakin gwamnati a cikin mai haƙuri-mai bayarwa dangantaka. Nass ya ce:
[Wannan yaƙin] game da ko za a ƙyale likitoci da marasa lafiya a nan gaba su yanke shawara kan kula da marasa lafiya ko kuma za a yi kutse daga gwamnatin tarayya, kamfanonin inshora, WHO [Hukumar Lafiya ta Duniya], Majalisar Dinkin Duniya [Majalisar Dinkin Duniya], da sauransu waɗanda za su yi kiran harbi kuma suna gaya mana abin da za mu iya kuma ba za mu iya yi don kula da marasa lafiya ba.
A cikin fiye da shekaru talatin na aiki a matsayin likita, ba a sami ƙarar haƙuri ɗaya ba akan Nass. A gaskiya majiyyatan uku da Hukumar Maine ta Lasisin ta yi iƙirarin Dr. Nass ya cutar da su ta hanyar yi musu magani ga Covid tare da magungunan kashe-kashe (ciki har da HCQ da ivermectin) Hukumar ba ta ma yi hira da su ba.
Sai dai lauyan Nass ya tattauna da su, kuma dukkansu ukun sun nuna jin dadinsu da yadda Nass ke tafiyar da shari’o’insu, da kuma fushin cewa Hukumar ta yi wa Dr. Nass hari. Don }o}arin da ta yi, an saka lasisin likitancin Dr. Nass gwaji ta Maine Board ranar 26 ga Satumba, 2023. Dr. Nass ya shigar da karar a countersut a kan Hukumar saboda ramuwar gayya da aka yi mata, da kuma keta haƙƙinta na Gyaran Farko.
Kashe Hydroxychloroquine:
"Wane ne ko menene yake son raunata da kashe marasa lafiya don kashe amfani da hydroxychloroquine a cikin Covid-19?"
Dr. Meryl Nass
Yuni 19, 2020
Yuni 15, 2020 - FDA ta soke amincewar EUA na HCQ don kula da Covid-19:
Dogaro da skewed sakamakon daga Gwajin Farfadowa, a ranar 15 ga Yuni, 2020, FDA ta soke amincewar EUA na HCQ. The FDA faɗakarwa ya bayyana cewa "ci gaba da bitar shaidun kimiyya da ake samu don hydroxychloroquine sulfate… don magance Covid-19" ya ƙaddara cewa " yuwuwar fa'idodin… HCQ ba ta ƙara yin nauyi da sananne da haɗarin haɗari don amfani da izini ba."
Janyewar FDA na EUA don HCQ yana haifar da mutuwar haƙuri:
Sabanin ma'aikatan tsarin tsarin manufofin da ba su kula da marasa lafiya ba, likitocin takalma-a-kasa, irin su Dr. Zelenko da Dr. Didier Raoult, sun gano cewa HCQ da ivermectin (ivermectin an magance su daga baya a cikin wannan takarda) sun kasance wani ɓangare na tsarin da ya hana asibiti ga Covid, kuma ya rage tsawon lokacin rashin lafiya. Dr. Paul Marik, Likitan kula da lafiya na biyu da aka buga a duniya, an sake kirga shi a cikin Janairu 24, 2022 Tattaunawar majalisar dattawan Amurka tsananin damuwar sa lokacin da hukumar asibiti ta hana yin amfani da magungunan da aka sake amfani da su bayan da FDA ta janye EUA.
Don fayyace, alamar kashe-kashe tana nufin amfani da magani don kula da wani yanayi banda waɗanda aka jera akan alamar samfur. Rubuce-rubucen kashe-kashe wani muhimmin sashi ne a cikin aikin likitanci, kamar yadda likitoci ke amfani da iliminsu da hankalinsu wajen kula da kowane majiyyaci. Dr. Marik ya lura a cikin wani daga baya ji cewa kashi 40 cikin XNUMX na magungunan da ake amfani da su a asibitoci sune magungunan kashe-kashe, waɗanda ke amfani da FDA suna ƙarfafawa, kuma "kashe-lakabi kawai batun fasaha ne game da talla." Musamman, kamfanin magunguna ba zai iya tallata samfur don amfani da shi a kowane irin ƙarfin da FDA ta yarda da amfani da shi ba. Likitoci, duk da haka, za su iya ba da izini mara izini, kuma su raba sakamakon tare da abokan aiki.
A lokacin janyewar FDA na EUA don sake dawo da magungunan, mace-mace ga marasa lafiyar Marik tare da Covid sun kasance kashi 50 na abokan aikin sa, duk da haka an umarce shi da ya daina amfani da ka'idar tambarin da ya kirkira da yin amfani da remdesivir.
Marik ya ba da rahoto cikin motsin rai, "A karo na farko a cikin dukan aikina [40], ba zan iya zama likita ba. Don yin magana a asibitinsa, Marik ya rasa gatansa na asibiti kuma an kai rahoto ga ma'aikacin bayanai na kasa, mai yuwuwar kawo karshen aikinsa na likitanci.
Dalilin riba bayan kashe HCQ:
Game da dakatar da amfani da HCQ, Dr. Nass ya kammala. "WHO da sauran hukumomin kiwon lafiya na kasa, jami'o'i da kungiyoyin agaji sun gudanar da manyan gwaje-gwaje na asibiti wadanda aka tsara don haka hydroxychloroquine zai gaza. don nuna fa'ida a cikin maganin Covid-19, watakila don cin gajiyar fafatawa da masu fafatawa masu tsada da alluran rigakafi wajen haɓakawa, wanda masu tallafawa gwaji na Solidarity da farfadowa da kuma masu tallafawa na WHO suka sami tallafi sosai."
Robert F. Kennedy, Jr bayyana ta wannan hanyar a 2022:
Akwai nazarin 400 da ke nuna fa'idodi daga hydroxychloroquine da kusan karatun 100, ina tsammanin 99, wanda ke nuna matuƙar fa'ida… na ivermectin. Sannan akwai ’yan kadan daga cikin nazarce-nazarcen da gwamnati ta samar, wanda WHO ta yi, wanda Bill Gates ya ba da kuxinsa, wanda ya ce babu wani fa’ida, amma waxannan binciken na da matsaloli da dama.
Gwajin Solidarity na WHO ya gwada remdesivir, hydroxychloroquine, da wasu magunguna guda biyu don tasiri kan Covid-19. The Fauci da FDA sun yi watsi da bayanin WHO na cewa bai kamata a yi amfani da remdesivir ba. An yi amfani da sabotage na WHO na HCQ don murkushe maganin ceton rai don neman maganin remdesivir mai guba, da kuma samar da hanyar harbin Covid da ba dole ba.
-
Lori Weintz yana da Bachelor of Arts a Mass Communications daga Jami'ar Utah kuma a halin yanzu yana aiki a cikin tsarin ilimin jama'a na K-12. A baya ta yi aiki a matsayin jami'in zaman lafiya na musamman wanda ke gudanar da bincike don Sashen Lasisi na Sana'a da Ƙwararru.
Duba dukkan posts
